PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ospemifene - Vaginal atrophy
PAD Profile : Ospemifene - Vaginal atrophy
Keywords :
menopause, menopausal symptoms, vaginal oestrogen, oestrogen deficiency, vaginal dryness, selective oestrogen receptor modulators
Brand Names Include :
Senshio
Traffic Light Status
Status 1 of 1.
Status :
Blue
Important
Formulations :
- Tablets
Important Information :
Initiation in primary care following specialist recommendation. Reserve for severe dryness or when other treatments are ineffective / contraindicated.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
03 July 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands APC has agreed a traffic light status and place in therapy for the treatments of menopausal disorders in line with the CKS recommenations:
Associated BNF Codes
06. Endocrine System
06.04.01. Female sex hormones and their modulators
07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.02.01. Preparations for vaginal and vulval changes